LEO Pharma divests four medicines to Cheplapharm for $357m
Danish medical dermatology company LEO Pharma has divested a portfolio of four non-core medicines to German pharmaceutical firm Cheplapharm for…
Latest Deals
-
PermiraMergers & Acquisitions $1.8BN
-
Bausch HealthLicensing Agreement $50M
-
RocheMergers & Acquisitions $449M
-
Palleon PharmaceuticalsCapital Raising $100M
-
PermiraMergers & Acquisitions $1.8BN
-
Bausch HealthLicensing Agreement $50M
-
RocheMergers & Acquisitions $449M
-
Palleon PharmaceuticalsCapital Raising $100M
Bayer invests in cancer therapies developer Triumvira Immunologics
Bayer's investment unit Leaps by Bayer and Northpond Ventures led the $55m Series A funding round of cancer therapies developer…
Latest News
View More
Fujifilm to seek approval for Avigan in Covid-19 after positive data
Japan's Fujifilm Toyama Chemical plans to seek approval for its anti-viral drug Avigan (favipiravir) to treat patients with Covid-19, after obtaining positive results in Phase…
Scenic Biotech forms drug development alliance with Genentech
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a bid to discover, develop and commercialise new drugs against genetic…
Bausch Health to acquire ophthalmology assets of Allegro
Bausch Health has signed an agreement to acquire an option to buy biopharmaceutical company Allegro Ophthalmics’ ophthalmological assets. The option…
Samsung Biologics signs $330m deal to produce AstraZeneca’s therapies
South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at approximately $330.8m, with AstraZeneca. Under…
Roche acquires biotech firm Inflazome for $449m
Roche has completed a share purchase agreement to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m).…
Sanofi and GSK agree to supply Covid-19 vaccine doses to EU
Sanofi and GlaxoSmithKline (GSK) have signed an advanced purchase agreement with the European Commission (EC) to supply up to 300…
Company A-Z
View More
Latest Content
View MoreDevelopment and Production of the Respimat® Reuseable Inhaler Housing Module
Boehringer Ingelheim commissioned Gerresheimer to develop and produce on a large scale the housing module for the new generation of…
Technology Partners
Developed to nurture an ecosystem that digitises the workforce, Nymi unites a complete set of benefits aimed at onboarding teams…
Quality Statement
Nymi executed a Quality Management System (QMS) that aligns with its consumer demands and leads the development of products and…
Solution Overview
Healthcare industries struggle to deliver the advantages of digital transformation (DX), as commonplace solutions entail trade-offs between security, compliance, and…